Loading...
Loading...
India's celecoxib imports from BRAZIL total $242 across 1 shipments from 1 foreign suppliers. ZYDUS NIKKHO FARMACEUTICA LTDA leads with $242 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ZYDUS HEALTHCARE LIMITED. This corridor reflects India's pharmaceutical import demand for celecoxib — a concentrated sourcing relationship with select suppliers from BRAZIL.

ZYDUS NIKKHO FARMACEUTICA LTDA is the leading Celecoxib supplier from BRAZIL to India, with import value of $242 across 1 shipments. The top 5 suppliers — ZYDUS NIKKHO FARMACEUTICA LTDA — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS NIKKHO FARMACEUTICA LTDA | $242 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS HEALTHCARE LIMITED | $242 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Celecoxib suppliers from BRAZIL to India include ZYDUS NIKKHO FARMACEUTICA LTDA. The leading supplier is ZYDUS NIKKHO FARMACEUTICA LTDA with import value of $242 USD across 1 shipments. India imported Celecoxib worth $242 USD from BRAZIL in total across 1 shipments.
India imported Celecoxib worth $242 USD from BRAZIL across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Celecoxib sourced from BRAZIL include ZYDUS HEALTHCARE LIMITED. The largest buyer is ZYDUS HEALTHCARE LIMITED with $242 in imports across 1 shipments.
The total value of Celecoxib imports from BRAZIL to India is $242 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists